Hydralazine Hydrochloride Injection, Solution
Product Images NDC 51662-1648

This is information for Hydralazine hydrochloride injection, USP28mg/mL 1mL Vial, intended for intramuscular or intravenous use in emergency situations for patients who are unable to take oral medication. Each ml contains Hydralazine hydrochloride 20mg, Propylene glycol 103.6mg, Methylparaben 0.65mg, Propylparaben 0.35mg, and Water for injection. It is sterile and nonpyrogenic, with a pH of the solution between 3.4 - 4.4 and may be adjusted if needed. The medication should be stored between 20 - 25ºC (68-77ºF). For detailed directions on usage, refer to the package insert. It is manufactured by HF Acquisition Co., LLC in Mukilteo, WA 98275.*

This is a description of a pharmaceutical product called HYDRALAZINE HYDROCHLORIDE INJECTION, USP. This product comes in vials containing 20mg/mL of solution, with each vial holding 1mL. Each case contains 25 vials. The medication is for intramuscular or intravenous use and is designed for emergency use in patients who cannot take oral medication. The ingredients in each mL include Hydralazine Hydrochloride (20mg), Propylene Glycol (183.6mg), Methylparaben (0.65mg), Propylparaben (0.35mg), and water for injection. The solution has a pH range of 3.4-4.4 and can be adjusted if needed. It is a sterile, nonpyrogenic product. Unused portions should be discarded, and it should be stored at 20-25°C. Refer to the package insert for directions for use. The product is manufactured by HFAcquisitionCo., LLC in Mukilteo, WA 98275. Original manufacturer NDC: 8517-8981-25.*

This text contains a unique identification number along with a manufacturer's package insert disclaimer. The product is distributed by HF Acquisition Co., LLC located in Mukilteo, WA 98275, and is intended for prescription use only.*